Maxi Cal 1000
Natural health product licensed in Canada
- Other names
- MAXI CAL 1000, Maxi Cal, Maxi Cal Calcium Magnesium D3
- Licence holder
- Maxi-Health Research LLC.
- NPN or DIN-HM
- 80057805
- Status
- Active licence
- Licence date
- 30 January 2015
- Revision date
- 8 April 2016
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Calcium: up to 1,000 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 800 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Magnésium: up to 500 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 500 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Papaïne Source : Papain | 48,000 FCC PU | Not calculated |
| Papaïne Source : Papain | 1 mg | Not calculated |
| Papaïne Source : Carica papaya - fruit | 48,000 FCC PU | Not calculated |
| Papaïne Source : Carica papaya - fruit | 1 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 5 FCC DU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 5 FCC DU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 1 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 1 mg | Not calculated |
| Calcium Source : Citrate de calcium | 250 mg | 1,000,000 µg |
| Calcium Source : Carbonate de calcium | 250 mg | 1,000,000 µg |
| Magnésium Source : Oxyde de magnésium | 125 mg | 500,000 µg |
| Bromélaïne de fruit Source : Bromélaïne de fruit | 36,000 FCC PU | Not calculated |
| Bromélaïne de fruit Source : Ananas comosus var. comosus - fruit | 36,000 FCC PU | Not calculated |
| Bromélaïne de fruit Source : Bromélaïne de fruit | 1 mg | Not calculated |
| Bromélaïne de fruit Source : Ananas comosus var. comosus - fruit | 1 mg | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 5 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 5 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 1 mg | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 1 mg | Not calculated |
| Protéase fongique Source : Protéase fongique | 1 mg | Not calculated |
| Protéase fongique Source : Protéase fongique | 5 FCC HUT | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 1 mg | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 5 FCC HUT | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Carbonate de calcium, Cellulose microcristalline, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones and teeth. Helps in tissue formation and to maintain proper muscle function. Digestive Enzyme.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80057805
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging